PapersFlow Research Brief
Diabetes and associated disorders
Research Guide
What is Diabetes and associated disorders?
Diabetes and associated disorders refer to a cluster of conditions centered on type 1 diabetes, encompassing its genetics, pathogenesis, treatment strategies, HLA gene roles, environmental triggers, autoimmune responses, insulin production defects, immunotherapy approaches, epidemiology, and C-peptide levels.
This field includes 94,631 papers on type 1 diabetes genetics, autoimmunity, and related mechanisms. Key areas cover HLA genes, islet autoimmunity, insulin production, and environmental triggers. Growth rate over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
HLA Class II Genetic Risk Factors in Type 1 Diabetes
Researchers analyze DR3-DQ2 and DR4-DQ8 haplotypes' associations with T1D susceptibility across populations using high-resolution sequencing. Functional studies explore antigen presentation efficiency and thymic selection biases.
Environmental Triggers of Islet Autoimmunity
Prospective birth cohorts identify enterovirus infections, early cow's milk exposure, and vitamin D deficiency precipitating autoantibody seroconversion. Mechanistic research links gut permeability and microbiome dysbiosis to beta-cell attack initiation.
C-Peptide as Biomarker of Residual Beta-Cell Function
Studies validate stimulated C-peptide assays for tracking honeymoon phase duration and therapeutic preservation of insulin secretion. Honeymoon predictors include low autoantibody titers and rapid metabolic decompensation avoidance.
Immunotherapy Trials for New-Onset Type 1 Diabetes
Clinical trials test anti-CD3 (teplizumab), rituximab, and IL-2 agonists for preserving C-peptide in recent-onset patients. Biomarker stratification identifies immune responders and long-term metabolic benefits.
Epidemiology of Type 1 Diabetes Incidence Trends
Global registries document rising pediatric-onset rates in developed nations, analyzing birth cohort effects, migration studies, and accelerator hypotheses. Projections model future burdens under climate and urbanization scenarios.
Why It Matters
Standardized diagnosis and classification of diabetes enable consistent clinical identification and management of hyperglycemia-linked organ damage. Alberti et al. (1998) in "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation" established criteria updated by the American Diabetes Association (2010) in "Diagnosis and Classification of Diabetes Mellitus," cited 13,975 times, facilitating global prevalence tracking. Saeedi et al. (2019) estimated 463 million adults with diabetes in 2019, projecting 700 million by 2045 in "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition," informing public health responses. Hotamışlıgil et al. (1993) linked TNF-α in adipose tissue to obesity-related insulin resistance in type 2 diabetes contexts, cited 7,384 times, advancing metabolic disorder therapies.
Reading Guide
Where to Start
"Diagnosis and Classification of Diabetes Mellitus" by American Diabetes Association (2010) provides foundational diagnostic criteria and hyperglycemia definitions, serving as an accessible entry point before genetics-focused works.
Key Papers Explained
Alberti et al. (1998) in "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation" set early WHO standards, refined by American Diabetes Association (2010) in "Diagnosis and Classification of Diabetes Mellitus" and The Expert Committee (2002) in "Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus." Saeedi et al. (2019) in "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition" builds epidemiological context, while Hotamışlıgil et al. (1993) in "Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance" connects to associated insulin resistance mechanisms.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus remains on HLA genetics, autoimmunity, and immunotherapy in type 1 diabetes per cluster data, with no recent preprints or news shifting priorities.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Definition, diagnosis and classification of diabetes mellitus ... | 1998 | Diabetic Medicine | 15.2K | ✕ |
| 2 | Diagnosis and Classification of Diabetes Mellitus | 2010 | Diabetes Care | 14.0K | ✓ |
| 3 | Report of the Expert Committee on the Diagnosis and Classifica... | 2002 | Diabetes Care | 10.4K | ✕ |
| 4 | Global and regional diabetes prevalence estimates for 2019 and... | 2019 | Diabetes Research and ... | 10.0K | ✕ |
| 5 | Biological insights from 108 schizophrenia-associated genetic ... | 2014 | Nature | 8.0K | ✓ |
| 6 | Adipose Expression of Tumor Necrosis Factor-α: Direct Role in ... | 1993 | Science | 7.4K | ✕ |
| 7 | IDF Diabetes Atlas: Global estimates of diabetes prevalence fo... | 2018 | Diabetes Research and ... | 7.1K | ✕ |
| 8 | Diagnosis and Classification of Diabetes Mellitus | 2013 | Diabetes Care | 5.9K | ✓ |
| 9 | Global and societal implications of the diabetes epidemic | 2001 | Nature | 5.9K | ✓ |
| 10 | Global aetiology and epidemiology of type 2 diabetes mellitus ... | 2017 | Nature Reviews Endocri... | 5.4K | ✕ |
Frequently Asked Questions
What is the definition of diabetes mellitus?
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia from defects in insulin secretion, insulin action, or both. Chronic hyperglycemia leads to long-term damage, dysfunction, and failure of organs, especially eyes, kidneys, nerves, heart, and blood vessels. American Diabetes Association (2010) in "Diagnosis and Classification of Diabetes Mellitus" outlines these criteria.
How is diabetes diagnosed and classified?
Diagnosis relies on tests standardizing hyperglycemia thresholds, with classification distinguishing type 1 from type 2 based on etiology. The Expert Committee (2002) in "Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus" refined categories from prior WHO consultations. Alberti et al. (1998) provided provisional WHO guidelines on diagnosis and classification.
What are the global prevalence estimates for diabetes?
In 2019, 463 million adults had diabetes, projected to reach 700 million by 2045. Saeedi et al. (2019) reported these figures in "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition." Cho et al. (2018) estimated prevalence for 2017 with projections to 2045 in "IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045."
What role does TNF-α play in diabetes-associated insulin resistance?
TNF-α expression increases in adipose tissue of obesity and diabetes models, contributing directly to insulin resistance. Hotamışlıgil et al. (1993) demonstrated elevated TNF-α mRNA and protein in rodent models in "Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance." This links inflammation to metabolic dysfunction.
What are the genetic factors in type 1 diabetes?
HLA genes play a central role in type 1 diabetes susceptibility and autoimmunity. The cluster description highlights HLA genes alongside insulin production genetics and islet autoimmunity. Epidemiology ties these to C-peptide levels and disease progression.
What drives the diabetes epidemic?
Changes in human behavior and lifestyle over the last century increased diabetes incidence, mainly type 2 with associated 'diabesity' and metabolic syndrome. Zimmet et al. (2001) detailed global implications in "Global and societal implications of the diabetes epidemic." Genetic susceptibility interacts with these environmental shifts.
Open Research Questions
- ? How do specific HLA gene variants interact with environmental triggers to initiate islet autoimmunity in type 1 diabetes?
- ? What mechanisms link declining C-peptide levels to progression from autoimmunity to insulin dependence?
- ? Can targeted immunotherapy reverse autoimmune destruction of beta cells in early-stage type 1 diabetes?
- ? How do genetic factors in insulin production genes modify type 1 diabetes risk across populations?
- ? What environmental exposures most strongly predict type 1 diabetes onset in genetically susceptible individuals?
Recent Trends
No recent preprints or news coverage available in the past 6-12 months; sustained emphasis on type 1 diabetes genetics, HLA genes, and epidemiology persists across 94,631 papers.
Research Diabetes and associated disorders with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Diabetes and associated disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers